Los Angeles Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Sell
33,588
-10,457
-24% -$79.9K ﹤0.01% 1075
2025
Q4
$451K Buy
44,045
+1,271
+3% +$10.8K ﹤0.01% 929
2025
Q3
$179K Sell
42,774
-648
-1% -$4.14K ﹤0.01% 1284
2025
Q2
$403K Buy
+43,422
New +$379K ﹤0.01% 942
2025
Q1
Sell
-34,547
Closed -$418K 1198
2024
Q4
$418K Sell
34,547
-24,040
-41% -$292K ﹤0.01% 855
2024
Q3
$642K Sell
58,587
-13,228
-18% -$134K ﹤0.01% 795
2024
Q2
$646K Buy
71,815
+5,410
+8% +$37.7K ﹤0.01% 787
2024
Q1
$543K Buy
66,405
+30,203
+83% +$248K ﹤0.01% 848
2023
Q4
$305K Buy
+36,202
New +$420K ﹤0.01% 1012

Other funds holding REPL

Los Angeles Capital Management's REPL Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Replimune Group (REPL) stake by 24% in Q1 2026, selling an estimated $79.9K and leaving 33,588 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Los Angeles Capital Management first reported a position in REPL in Q4 2023 and has held it in 9 quarters since. The position peaked at $646K in Q2 2024. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Los Angeles Capital Management held 33,588 shares of Replimune Group worth $257K as of Q1 2026.
  • Los Angeles Capital Management sold 10,457 Replimune Group shares in Q1 2026, an estimated $79.9K.
  • Replimune Group made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #1075 holding.
  • Los Angeles Capital Management first reported a position in Replimune Group in Q4 2023 and has held it in 9 quarters since.
  • Los Angeles Capital Management's Replimune Group position peaked at $646K in Q2 2024.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.